ENZYME-LINKED IMMUNOSORBENT ASSAY
- Interpreting serologic tests for hepatitis C virus infection: balancing cost and clarity
ELISA screening tests for HCV have unacceptably high false-positive rates. Newer tests are more accurate, but costly.
ELISA screening tests for HCV have unacceptably high false-positive rates. Newer tests are more accurate, but costly.